Compare GGG & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GGG | ELAN |
|---|---|---|
| Founded | 1926 | 1954 |
| Country | United States | United States |
| Employees | N/A | 9900 |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 13.2B |
| IPO Year | 1994 | 2018 |
| Metric | GGG | ELAN |
|---|---|---|
| Price | $72.56 | $26.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 16 |
| Target Price | ★ $83.29 | $31.00 |
| AVG Volume (30 Days) | 2.0M | ★ 5.3M |
| Earning Date | 10-21-2026 | 11-06-2026 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | ★ 9.22 | N/A |
| EPS | ★ 2.32 | 0.26 |
| Revenue | $2,236,604,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $4.86 | $10.10 |
| Revenue Next Year | $7.74 | $4.97 |
| P/E Ratio | ★ $31.13 | $102.13 |
| Revenue Growth | 5.83 | ★ 6.22 |
| 52 Week Low | $65.96 | $19.40 |
| 52 Week High | $95.69 | $27.98 |
| Indicator | GGG | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 68.11 |
| Support Level | $66.48 | $21.98 |
| Resistance Level | $77.70 | $27.85 |
| Average True Range (ATR) | 1.67 | 0.92 |
| MACD | 0.65 | 0.33 |
| Stochastic Oscillator | 85.95 | 89.70 |
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2025.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.